Since health insurance is tied to employment in the United States, Americans are losing their insurance just as they need it most. We asked economist Fiona Scott Morton, an expert on the healthcare industry, what a better system would look like.
In the face of pressure from President Donald Trump, nine major pharmaceutical companies have signed a pledge to complete testing before submitting vaccines for approval. Yale's Jeffrey Sonnenfeld and Dr. Albert Ko write that the drugmakers’ caution may help provide badly needed confidence in the eventual vaccine.
Yale SOM’s Jason Abaluck and his co-authors calculated that the Medicare Advantage plans appreciably influence the survival rates of their enrollees. Shutting down the plans with the highest mortality rates could save thousands of lives per year.
Nicolas Encina ’10 and his colleagues at Ariadne Labs have been demonstrating the potential of a collaborative, multidisciplinary process for designing and scaling simple improvements to healthcare—and also its limits.